Differences arise in the immediate outputs—glutaminolysis via SLC7A5 in NSCLC, fatty-acid activation via ACSL3 in CRC, and pro-migratory signaling via RAC3—and in whether CAFs act primarily by secreting a writer versus inducing tumor writers through growth-factor signaling. The gene discussed is RAC3; the disease is non-small cell lung carcinoma.